At the nucleus of SCVI is a richly diverse group of 178 University faculty scientists, scholars, engineers and adult and pediatric clinicians whose multidisciplinary collaborations will focus on the prevention, treatment, and ultimate elimination of cardiovascular diseases.
SCVI is one of four institutes established by Stanford School of Medicine to be the pillars of its future interdisciplinary efforts in understanding, preventing and treating human disease.
The Stanford Cardiovascular Institute will:
Develop and pioneer integrative strategies to prevent, treat and ultimately cure heart disease
Advance the frontiers of cardiovascular medicine
Translate the extraordinary progress of science and technology into new applications
Donna Jackson's heart, on the verge of failing two years earlier, had made a strong recovery. By spring 2013, she no longer needed the left ventricular assist device, or LVAD, that had been implanted in her chest almost three years earlier.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.